(Q58088776)

English

The Lescol ® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

journal article; published in Acute Cardiac Care in 2001

In more languages

Statements

scholarly article

2 references

Taylor & Francis Online

https://www.tandfonline.com/doi/abs/10.1080/14628840127765

28 October 2018

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

The Lescol(R) Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

Emmanuel Lesaffre

5

object named as

Emmanuel Lesaffre

0 references

author name string

Patrick WJC Serruys

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Renée Benghozi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Paul G Hugenholtz

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Pim J De Feyter

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Emmanuel Lesaffre

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

official website

https://www.tandfonline.com/doi/abs/10.1080/14628840127765

1 reference

International journal of cardiovascular interventions

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

4

2 references

Taylor & Francis Online

https://www.tandfonline.com/doi/abs/10.1080/14628840127765

28 October 2018

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

4

2 references

Taylor & Francis Online

https://www.tandfonline.com/doi/abs/10.1080/14628840127765

28 October 2018

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

165-172

2 references

Taylor & Francis Online

https://www.tandfonline.com/doi/abs/10.1080/14628840127765

28 October 2018

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients.

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Discrete sequential boundaries for clinical trials

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Early detection of high cholesterol levels in young adults

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial)

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

The effects of lowering serum cholesterol on coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

[Comparison between PTCA and bypass operation. Results of large randomized studies]

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Unstable angina. A classification

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy

1 reference

https://api.crossref.org/works/10.1080%2F14628840127765

21 January 2018

Identifiers

10.1080/14628840127765

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12036459%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58088776&oldid=1630063777"